Quest Diagnostics Newsroom

Quest Diagnostics Analyst Ratings

BenzingaJul 5 19:27

Baird Adjusts Price Target on Quest Diagnostics to $153 From $145, Maintains Neutral Rating

MT NewswiresJul 5 17:59

Barclays Sticks to Their Hold Rating for Quest Diagnostics (DGX)

TipRanksJul 5 17:29

Buy Rating Affirmed: Quest Diagnostics' Strategic Acquisition of LifeLabs Poised to Boost Growth and Profitability

TipRanksJul 4 21:09

Nephron Adjusts Price Target on Quest Diagnostics to $155 From $152

MT NewswiresJul 3 21:59

Quest Diagnostics Analyst Ratings

BenzingaMay 31 02:05

JPMorgan Adjusts Price Target on Quest Diagnostics to $155 From $152

MT NewswiresMay 30 20:44

Quest Diagnostics Inc: J.P. Morgan raises price target from $152 to $155

Zhitong FinanceMay 30 12:29

Argus Adjusts Price Target on Quest Diagnostics to $215 From $163, Keeps Buy Rating

MT NewswiresMay 16 17:42

Argus Raises Quest Diagnostics' Price Target to $163 From $155

MT NewswiresMay 16 01:50

Buy Rating Affirmed for Quest Diagnostics on Strong Earnings Visibility and Growth Prospects

TipRanksMay 14 17:15

Baird Adjusts Quest Diagnostics' Price Target to $144 From $138

MT NewswiresApr 30 20:38

Piper Sandler Reaffirms Their Hold Rating on Quest Diagnostics (DGX)

TipRanksApr 30 19:15

Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Quest Diagnostics (DGX) and Healthcare Services (HCSG)

TipRanksApr 26 15:12

Quest Diagnostics: A Hold Rating Amid Solid Earnings and Strategic Caution

TipRanksApr 26 14:21

Barclays: Maintaining the Quest Diagnostics (DGX.US) rating, adjusted from a wait-and-see shareholding rating to a shareholding wait-and-see rating, and the target price was adjusted from $138.00 to $144.00.

Zhitong FinanceApr 26 02:41

Quest Diagnostics Analyst Ratings

BenzingaApr 26 02:40

Citi: Maintains Quest Diagnostics (DGX.US) rating, adjusted from neutral to neutral, and adjusted the target price from $135.00 to $145.00.

Zhitong FinanceApr 25 02:10

Deutsche Bank Adjusts Quest Diagnostics Price Target to $136 From $125, Maintains Hold Rating

MT NewswiresApr 24 21:12

Quest Diagnostics Analyst Ratings

BenzingaApr 24 19:55